Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 26 October 1990:
Vol. 250. no. 4980, pp. 553 - 556
DOI: 10.1126/science.2237407

Articles

Science, Vol 250, Issue 4980, 553-556
Copyright © 1990 by American Association for the Advancement of Science


articles

Protection of mice against the Lyme disease agent by immunizing with recombinant OspA

E Fikrig, SW Barthold, FS Kantor, and RA Flavell

Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06510.

Lyme borreliosis is a tick-borne illness caused by Borrelia burgdorferi. The gene for outer surface protein A (OspA) from B. burgdorferi strain N40 was cloned into an expression vector and expressed in Escherichia coli. C3H/HeJ mice actively immunized with live transformed E. coli or purified recombinant OspA protein produced antibodies to OspA and were protected from challenge with several strains of B. burgdorferi. Recombinant OspA is a candidate for a vaccine for Lyme borreliosis.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis.
U. Pal, P. Wang, F. Bao, X. Yang, S. Samanta, R. Schoen, G. P. Wormser, I. Schwartz, and E. Fikrig (2008)
J. Exp. Med. 205, 133-141
   Abstract »    Full Text »    PDF »
Lyme Arthritis: Current Concepts and a Change in Paradigm.
D. T. Nardelli, S. M. Callister, and R. F. Schell (2008)
Clin. Vaccine Immunol. 15, 21-34
   Full Text »    PDF »
Prostaglandin E2 Is a Major Inhibitor of Dendritic Cell Maturation and Function in Ixodes scapularis Saliva.
A. Sa-Nunes, A. Bafica, D. A. Lucas, T. P. Conrads, T. D. Veenstra, J. F. Andersen, T. N. Mather, J. M. C. Ribeiro, and I. M. B. Francischetti (2007)
J. Immunol. 179, 1497-1505
   Abstract »    Full Text »    PDF »
Constitutive Expression of Outer Surface Protein C Diminishes the Ability of Borrelia burgdorferi To Evade Specific Humoral Immunity.
Q. Xu, S. V. Seemanapalli, K. McShan, and F. T. Liang (2006)
Infect. Immun. 74, 5177-5184
   Abstract »    Full Text »    PDF »
A Database of Bacterial Lipoproteins (DOLOP) with Functional Assignments to Predicted Lipoproteins..
M. M. Babu, M. L. Priya, A. T. Selvan, M. Madera, J. Gough, L. Aravind, and K. Sankaran (2006)
J. Bacteriol. 188, 2761-2773
   Abstract »    Full Text »    PDF »
Interleukin-6 Promotes Anti-OspA Borreliacidal Antibody Production In Vitro.
E. L. Munson, D. T. Nardelli, K. H. K. Luk, M. C. Remington, S. M. Callister, and R. F. Schell (2006)
Clin. Vaccine Immunol. 13, 19-25
   Abstract »    Full Text »    PDF »
Borrelia burgdorferi Regulates Expression of Complement Regulator-Acquiring Surface Protein 1 during the Mammal-Tick Infection Cycle.
K. von Lackum, J. C. Miller, T. Bykowski, S. P. Riley, M. E. Woodman, V. Brade, P. Kraiczy, B. Stevenson, and R. Wallich (2005)
Infect. Immun. 73, 7398-7405
   Abstract »    Full Text »    PDF »
A Small Molecule {alpha}4{beta}1 Antagonist Prevents Development of Murine Lyme Arthritis without Affecting Protective Immunity.
J. Glasner, H. Blum, V. Wehner, H. U. Stilz, J. D. Humphries, G. P. Curley, A. P. Mould, M. J. Humphries, R. Hallmann, M. Rollinghoff, et al. (2005)
J. Immunol. 175, 4724-4734
   Abstract »    Full Text »    PDF »
The Calcium-binding Protein S100A2 Interacts with p53 and Modulates Its Transcriptional Activity.
A. Mueller, B. W. Schafer, S. Ferrari, M. Weibel, M. Makek, M. Hochli, and C. W. Heizmann (2005)
J. Biol. Chem. 280, 29186-29193
   Abstract »    Full Text »    PDF »
Interactions of OspA Monoclonal Antibody C3.78 with Borrelia burgdorferi within Ticks.
C. L. Gipson and A. M. de Silva (2005)
Infect. Immun. 73, 1644-1647
   Abstract »    Full Text »    PDF »
Evidence of Borrelia Autoimmunity-Induced Component of Lyme Carditis and Arthritis.
E. S. Raveche, S. E. Schutzer, H. Fernandes, H. Bateman, B. A. McCarthy, S. P. Nickell, and M. W. Cunningham (2005)
J. Clin. Microbiol. 43, 850-856
   Abstract »    Full Text »    PDF »
Relative Contributions of Innate and Acquired Host Responses to Bacterial Control and Arthritis Development in Lyme Disease.
X. Wang, Y. Ma, J. H. Weis, J. F. Zachary, C. J. Kirschning, and J. J. Weis (2005)
Infect. Immun. 73, 657-660
   Abstract »    Full Text »    PDF »
Protective Niche for Borrelia burgdorferi to Evade Humoral Immunity.
F. T. Liang, E. L. Brown, T. Wang, R. V. Iozzo, and E. Fikrig (2004)
Am. J. Pathol. 165, 977-985
   Abstract »    Full Text »    PDF »
Whole-Genome DNA Array Analysis of the Response of Borrelia burgdorferi to a Bactericidal Monoclonal Antibody.
J. M. Anderton, R. Tokarz, C. D. Thill, C. J. Kuhlow, C. S. Brooks, D. R. Akins, L. I. Katona, and J. L. Benach (2004)
Infect. Immun. 72, 2035-2044
   Abstract »    Full Text »    PDF »
Borrelia Outer Membrane Surface Proteins and Transmission Through the Tick.
T. J. Templeton (2004)
J. Exp. Med. 199, 603-606
   Full Text »    PDF »
Neutralization of Gamma Interferon Augments Borreliacidal Antibody Production and Severe Destructive Lyme Arthritis in C3H/HeJ Mice.
E. L. Munson, D. J. DeCoster, D. T. Nardelli, D. M. England, S. M. Callister, and R. F. Schell (2004)
Clin. Vaccine Immunol. 11, 35-41
   Abstract »    Full Text »    PDF »
Immunogenicity of Borrelia burgdorferi Arthritis-Related Protein.
S. Feng, E. Hodzic, K. Freet, and S. W. Barthold (2003)
Infect. Immun. 71, 7211-7214
   Abstract »    Full Text »    PDF »
Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi.
R. D. Gilmore Jr, R. M. Bacon, A. M. Carpio, J. Piesman, M. C. Dolan, and M. L. Mbow (2003)
J. Med. Microbiol. 52, 551-556
   Abstract »    Full Text »    PDF »
Gamma Interferon Inhibits Production of Anti-OspA Borreliacidal Antibody In Vitro.
E. L. Munson, B. K. Du Chateau, J. R. Jensen, S. M. Callister, D. J. DeCoster, and R. F. Schell (2002)
Clin. Vaccine Immunol. 9, 1095-1101
   Abstract »    Full Text »    PDF »
Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody.
U. Pal, R. R. Montgomery, D. Lusitani, P. Voet, V. Weynants, S. E. Malawista, Y. Lobet, and E. Fikrig (2001)
J. Immunol. 166, 7398-7403
   Abstract »    Full Text »    PDF »
Major Histocompatibility Complex Class II-Independent Generation of Neutralizing Antibodies against T-Cell-Dependent Borrelia burgdorferi Antigens Presented by Dendritic Cells: Regulation by NK and {gamma}{delta} T Cells.
M. L. Mbow, N. Zeidner, R. D. Gilmore Jr., M. Dolan, J. Piesman, and R. G. Titus (2001)
Infect. Immun. 69, 2407-2415
   Abstract »    Full Text »    PDF »
Lyme Borreliosis in Rhesus Macaques: Effects of Corticosteroids on Spirochetal Load and Isotype Switching of Anti-Borrelia burgdorferi Antibody.
A. R. Pachner, K. Amemiya, M. Bartlett, H. Schaefer, K. Reddy, and W.-F. Zhang (2001)
Clin. Vaccine Immunol. 8, 225-232
   Abstract »    Full Text »    PDF »
C-Terminal Invariable Domain of VlsE May Not Serve as Target for Protective Immune Response against Borrelia burgdorferi.
F. T. Liang, M. B. Jacobs, and M. T. Philipp (2001)
Infect. Immun. 69, 1337-1343
   Abstract »    Full Text »    PDF »
VraA (BBI16) Protein of Borrelia burgdorferi Is a Surface-Exposed Antigen with a Repetitive Motif That Confers Partial Protection against Experimental Lyme Borreliosis.
M. Labandeira-Rey, E. A. Baker, and J. T. Skare (2001)
Infect. Immun. 69, 1409-1419
   Abstract »    Full Text »    PDF »
In Vitro and In Vivo Neutralization of the Relapsing Fever Agent Borrelia hermsii with Serotype-Specific Immunoglobulin M Antibodies.
A. G. Barbour and V. Bundoc (2001)
Infect. Immun. 69, 1009-1015
   Abstract »    Full Text »    PDF »
Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks.
J. Ohnishi, J. Piesman, and A. M. de Silva (2001)
PNAS 98, 670-675
   Abstract »    Full Text »    PDF »
Production of Borreliacidal Antibody to Outer Surface Protein A In Vitro and Modulation by Interleukin-4.
E. L. Munson, B. K. Du Chateau, D. A. Jobe, S. D. Lovrich, S. M. Callister, and R. F. Schell (2000)
Infect. Immun. 68, 5496-5501
   Abstract »    Full Text »    PDF »
Identification of Group B Streptococcal Sip Protein, Which Elicits Cross-Protective Immunity.
B. R. Brodeur, M. Boyer, I. Charlebois, J. Hamel, F. Couture, C. R. Rioux, and D. Martin (2000)
Infect. Immun. 68, 5610-5618
   Abstract »    Full Text »    PDF »
Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant.
P. KRAICZY, K.-P. HUNFELD, S. PETERS, R. WURZNER, G. ACKER, B. WILSKE, and V. BRADE (2000)
J. Med. Microbiol. 49, 917-928
   Abstract »    Full Text »    PDF »
Comparison of Protection in Rabbits against Host-Adapted and Cultivated Borrelia burgdorferi following Infection-Derived Immunity or Immunization with Outer Membrane Vesicles or Outer Surface Protein A.
E. S. Shang, C. I. Champion, X.-Y. Wu, J. T. Skare, D. R. Blanco, J. N. Miller, and M. A. Lovett (2000)
Infect. Immun. 68, 4189-4199
   Abstract »    Full Text »    PDF »
Spirochaetal lipoproteins and pathogenesis.
D. A. Haake (2000)
Microbiology 146, 1491-1504
   Full Text »
Arthropod- and Host-Specific Borrelia burgdorferi bbk32 Expression and the Inhibition of Spirochete Transmission.
E. Fikrig, W. Feng, S. W. Barthold, S. R. Telford III, and R. A. Flavell (2000)
J. Immunol. 164, 5344-5351
   Abstract »    Full Text »    PDF »
Geographic clustering of an outer surface protein A mutant of Borrelia burgdorferi. Possible implications of multiple variants for Lyme disease persistence.
S. E. Malawista, R. R. Montgomery, X.-M. Wang, L. L. Fu, and S. S. Giles (2000)
Rheumatology 39, 537-541
   Abstract »    Full Text »    PDF »
The Lyme Disease Vaccine: Conception, Development, and Implementation.
W. T. Thanassi and R. T. Schoen (2000)
Ann Intern Med 132, 661-668
   Abstract »    Full Text »    PDF »
Prevention of Lyme Disease.
Committee on Infectious Diseases (2000)
Pediatrics 105, 142-147
   Abstract »    Full Text »    PDF »
Leptospiral Outer Membrane Proteins OmpL1 and LipL41 Exhibit Synergistic Immunoprotection.
D. A. Haake, M. K. Mazel, A. M. McCoy, F. Milward, G. Chao, J. Matsunaga, and E. A. Wagar (1999)
Infect. Immun. 67, 6572-6582
   Abstract »    Full Text »    PDF »
Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products.
E. Lien, T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, et al. (1999)
J. Biol. Chem. 274, 33419-33425
   Abstract »    Full Text »    PDF »
Molecular Typing of Borrelia burgdorferi Sensu Lato: Taxonomic, Epidemiological, and Clinical Implications.
G. Wang, A. P. van Dam, I. Schwartz, and J. Dankert (1999)
Clin. Microbiol. Rev. 12, 633-653
   Abstract »    Full Text »    PDF »
Comparative Analysis and Immunological Characterization of the Borrelia Bdr Protein Family.
W. R. Zuckert, J. Meyer, and A. G. Barbour (1999)
Infect. Immun. 67, 3257-3266
   Abstract »    Full Text »    PDF »
Access of Antibody or Trypsin to an Integral Outer Membrane Protein (P66) of Borrelia burgdorferi Is Hindered by Osp Lipoproteins.
J. Bunikis and A. G. Barbour (1999)
Infect. Immun. 67, 2874-2883
   Abstract »    Full Text »    PDF »
Influence of Outer Surface Protein A Antibody on Borrelia burgdorferi within Feeding Ticks.
A. M. de Silva, N. S. Zeidner, Y. Zhang, M. C. Dolan, J. Piesman, and E. Fikrig (1999)
Infect. Immun. 67, 30-35
   Abstract »    Full Text »    PDF »
Specificity of Infection-Induced Immunity among Borrelia burgdorferi Sensu Lato Species.
S. W. Barthold (1999)
Infect. Immun. 67, 36-42
   Abstract »    Full Text »    PDF »
The Immunoglobulin (IgG) Antibody Response to OspA and OspB Correlates with Severe and Prolonged Lyme Arthritis and the IgG Response to P35 Correlates with Mild and Brief Arthritis.
E. Akin, G. L. McHugh, R. A. Flavell, E. Fikrig, and A. C. Steere (1999)
Infect. Immun. 67, 173-181
   Abstract »    Full Text »    PDF »
Molecular Analysis of Sequence Heterogeneity among Genes Encoding Decorin Binding Proteins A and B of Borrelia burgdorferi Sensu Lato.
W. C. Roberts, B. A. Mullikin, R. Lathigra, and M. S. Hanson (1998)
Infect. Immun. 66, 5275-5285
   Abstract »    Full Text »    PDF »
DbpA, but Not OspA, Is Expressed by Borrelia burgdorferi during Spirochetemia and Is a Target for Protective Antibodies.
D. R. Cassatt, N. K. Patel, N. D. Ulbrandt, and M. S. Hanson (1998)
Infect. Immun. 66, 5379-5387
   Abstract »    Full Text »    PDF »
Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant.
A. C. Steere, V. K. Sikand, F. Meurice, D. L. Parenti, E. Fikrig, R. T. Schoen, J. Nowakowski, C. H. Schmid, S. Laukamp, C. Buscarino, et al. (1998)
N. Engl. J. Med. 339, 209-215
   Abstract »    Full Text »    PDF »
A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease.
L. H. Sigal, J. M. Zahradnik, P. Lavin, S. J. Patella, G. Bryant, R. Haselby, E. Hilton, M. Kunkel, D. Adler-Klein, T. Doherty, et al. (1998)
N. Engl. J. Med. 339, 216-222
   Abstract »    Full Text »    PDF »
Decorin-Binding Protein of Borrelia burgdorferi Is Encoded within a Two-Gene Operon and Is Protective in the Murine Model of Lyme Borreliosis.
K. E. Hagman, P. Lahdenne, T. G. Popova, S. F. Porcella, D. R. Akins, J. D. Radolf, and M. V. Norgard (1998)
Infect. Immun. 66, 2674-2683
   Abstract »    Full Text »    PDF »
Humoral Immunity to Borrelia burgdorferi N40 Decorin Binding Proteins during Infection of Laboratory Mice.
S. Feng, E. Hodzic, B. Stevenson, and S. W. Barthold (1998)
Infect. Immun. 66, 2827-2835
   Abstract »    Full Text »    PDF »
Active and Passive Immunity against Borrelia burgdorferi Decorin Binding Protein A (DbpA) Protects against Infection.
M. S. Hanson, D. R. Cassatt, B. P. Guo, N. K. Patel, M. P. McCarthy, D. W. Dorward, and M. Hook (1998)
Infect. Immun. 66, 2143-2153
   Abstract »    Full Text »    PDF »
Inhibition of the Production of Anti-OspA Borreliacidal Antibody with T Cells from Hamsters Vaccinated against Borrelia burgdorferi.
J. R. Jensen, B. K. Du Chateau, E. L. Munson, S. M. Callister, and R. F. Schell (1998)
Infect. Immun. 66, 1507-1512
   Abstract »    Full Text »    PDF »
A Surface-Exposed Region of a Novel Outer Membrane Protein (P66) of Borrelia spp. Is Variable in Size and Sequence.
J. Bunikis, C. J. Luke, E. Bunikiene, S. Bergström, and A. G. Barbour (1998)
J. Bacteriol. 180, 1618-1623
   Abstract »    Full Text »
Molecular Typing of Borrelia burgdorferi Sensu Lato by Randomly Amplified Polymorphic DNA Fingerprinting Analysis.
G. Wang, A. P. van Dam, L. Spanjaard, and J. Dankert (1998)
J. Clin. Microbiol. 36, 768-776
   Abstract »    Full Text »
Therapeutic passive vaccination against chronic Lyme disease in mice.
W. Zhong, T. Stehle, C. Museteanu, A. Siebers, L. Gern, M. Kramer, R. Wallich, and M. M. Simon (1997)
PNAS 94, 12533-12538
   Abstract »    Full Text »    PDF »
Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab.
H. Li, J. J. Dunn, B. J. Luft, and C. L. Lawson (1997)
PNAS 94, 3584-3589
   Abstract »    Full Text »    PDF »
The biological and social phenomenon of Lyme disease.
A. Barbour and D Fish (1993)
Science 260, 1610-1616
   Abstract »    PDF »
The Origin of Plagues: Old and New.
R. M. Krause (1992)
Science 257, 1073-1078
   Abstract »    PDF »
Biting back at Lyme disease..
J. Travis (1992)
Science 256, 1623
   PDF »
PROGRESS TOWARD A LYME DISEASE VACCINE.
(1990)
Journal Watch (General) 1990, 10
   Full Text »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)